202 related articles for article (PubMed ID: 32246859)
21. Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias.
Pariente A; Gregoire F; Fourrier-Reglat A; Haramburu F; Moore N
Drug Saf; 2007; 30(10):891-8. PubMed ID: 17867726
[TBL] [Abstract][Full Text] [Related]
22. SGLT-2 inhibitors and ketoacidosis: a disproportionality analysis in the World Health Organization's adverse drug reactions database.
Ado Moumouni AN; Robin P; Hillaire-Buys D; Faillie JL
Fundam Clin Pharmacol; 2018 Apr; 32(2):216-226. PubMed ID: 29144574
[TBL] [Abstract][Full Text] [Related]
23. Immune Checkpoint Inhibitors and Venous Thromboembolism: An Analysis of the WHO Pharmacovigilance Database.
Allouchery M; Beuvon C; Pérault-Pochat MC; Roblot P; Puyade M; Martin M
Clin Pharmacol Ther; 2022 Jul; 112(1):164-170. PubMed ID: 35426120
[TBL] [Abstract][Full Text] [Related]
24. Association of non-immediate drug hypersensitivity with drug exposure: A case control analysis of spontaneous reports from a Tunisian pharmacovigilance database.
Chaabane A; Fadhel NB; Chadli Z; Romdhane HB; Fredj NB; Boughattas NA; Aouam K
Eur J Intern Med; 2018 Jul; 53():40-44. PubMed ID: 29409745
[TBL] [Abstract][Full Text] [Related]
25. Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System.
Raschi E; Mazzarella A; Antonazzo IC; Bendinelli N; Forcesi E; Tuccori M; Moretti U; Poluzzi E; De Ponti F
Target Oncol; 2019 Apr; 14(2):205-221. PubMed ID: 30927173
[TBL] [Abstract][Full Text] [Related]
26. Calcitonin gene-related peptide antagonists in pregnancy: a disproportionality analysis in VigiBase
Noseda R; Bedussi F; Gobbi C; Ceschi A; Zecca C
J Headache Pain; 2024 Jan; 25(1):10. PubMed ID: 38243189
[TBL] [Abstract][Full Text] [Related]
27. Differences in VigiBase® reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment.
Sagwa EL; Souverein PC; Ribeiro I; Leufkens HG; Mantel-Teeuwisse AK
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):1-8. PubMed ID: 27868278
[TBL] [Abstract][Full Text] [Related]
28. Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database.
Revet A; Montastruc F; Roussin A; Raynaud JP; Lapeyre-Mestre M; Nguyen TTH
BMC Psychiatry; 2020 Jun; 20(1):308. PubMed ID: 32546134
[TBL] [Abstract][Full Text] [Related]
29. [Antidepressive agents and hypertension: A case/no-case study in French pharmacovigilance database].
Hofferer A; Dolladille C; Chretien B; Sassier M; Laugier D; Atzenhoffer M; Bagheri H; Alexandre J; Fedrizzi S; Humbert X
Encephale; 2022 Aug; 48(4):404-408. PubMed ID: 34311965
[TBL] [Abstract][Full Text] [Related]
30. Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database.
Capogrosso Sansone A; Convertino I; Galiulo MT; Salvadori S; Pieroni S; Knezevic T; Mantarro S; Marino A; Hauben M; Blandizzi C; Tuccori M
Drug Saf; 2017 Oct; 40(10):895-909. PubMed ID: 28681266
[TBL] [Abstract][Full Text] [Related]
31. Investigating the safety profiles of exogenous melatonin and associated adverse events: A pharmacovigilance study using WHO-VigiBase.
Ha M; Yoon D; Lee CY; Lee M; Kim YW; Lee JM; Shin JY
J Pineal Res; 2024 Mar; 76(2):e12949. PubMed ID: 38528668
[TBL] [Abstract][Full Text] [Related]
32. Analysis of immune-related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database.
Hasegawa S; Ikesue H; Nakao S; Shimada K; Mukai R; Tanaka M; Matsumoto K; Inoue M; Satake R; Yoshida Y; Goto F; Hashida T; Nakamura M
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1279-1294. PubMed ID: 32869941
[TBL] [Abstract][Full Text] [Related]
33. Thirst and drugs: A study in the World Health Organization's pharmacovigilance database.
Montastruc JL
Br J Clin Pharmacol; 2024 Jun; 90(6):1525-1528. PubMed ID: 38627211
[TBL] [Abstract][Full Text] [Related]
34. Statin-induced myasthenia: A disproportionality analysis of the WHO's VigiBase pharmacovigilance database.
Gras-Champel V; Batteux B; Masmoudi K; Liabeuf S
Muscle Nerve; 2019 Oct; 60(4):382-386. PubMed ID: 31298743
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular and gastrointestinal safety of selective cyclooxygenase-2 inhibitors: a case/non-case study.
Martin Arias LH; Martin Gonzalez A; Sanz Fadrique R; Salgueiro E; Sainz M
Int J Clin Pharm; 2018 Aug; 40(4):928-935. PubMed ID: 30066292
[TBL] [Abstract][Full Text] [Related]
36. Metabolic and Nutritional Disorders Following the Administration of Immune Checkpoint Inhibitors: A Pharmacovigilance Study.
Zhai Y; Ye X; Hu F; Xu J; Guo X; Zhou X; Zheng Y; Zhao X; Xu X; Cao Y; He J
Front Endocrinol (Lausanne); 2021; 12():809063. PubMed ID: 35145482
[TBL] [Abstract][Full Text] [Related]
37. Cardiac failure in patients treated with azacitidine, a pyrimidine analogue: Case reports and disproportionality analyses in Vigibase.
Perino J; Mottal N; Bohbot Y; Servant V; Berroneau A; Poustis P; Fenaux P; Laribi K; Charbonnier A; Bilion E; Calmettes C; Bégaud B; Pigneux A; Milpied N; Miremont-Salamé G; Théophile H; Dimicoli-Salazar S
Br J Clin Pharmacol; 2020 May; 86(5):991-998. PubMed ID: 31912911
[TBL] [Abstract][Full Text] [Related]
38. Withdrawal syndrome after antipsychotics discontinuation: an analysis of the WHO database of spontaneous reports (Vigibase) between 2000 and 2022.
Storck W; de Laportalière TT; Yrondi A; Javelot H; Berna F; Montastruc F
Psychopharmacology (Berl); 2024 Jun; 241(6):1205-1212. PubMed ID: 38376511
[TBL] [Abstract][Full Text] [Related]
39. Drug-induced acute pancreatitis due to medications used for inflammatory bowel disease: A VigiBase pharmacovigilance database study.
Lee AA; Gupta S; Labban M; Cao FT; Trinh QD; McNabb-Baltar J
Pancreatology; 2023 Sep; 23(6):569-573. PubMed ID: 37302896
[TBL] [Abstract][Full Text] [Related]
40. Safety profile of D-penicillamine: a comprehensive pharmacovigilance analysis by FDA adverse event reporting system.
Kumar V; Singh AP; Wheeler N; Galindo CL; Kim JJ
Expert Opin Drug Saf; 2021 Nov; 20(11):1443-1450. PubMed ID: 34259127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]